Abstract | PURPOSE: METHODS: Human osteoblasts were cultured in plain culture medium (DMEM). After 48 h, plain DMEM was replaced by DMEM with no fetal bovine serum, for a 24-h incubation followed by addition of zoledronic acid (5 μM) for additional 48 h. Cells were subjected to LLLT (InGaAsP; 780 ± 3 nm; 0.025 W) at 0.5, 1.5, 3, 5, and 7 J/cm(2), three times every 24 h. Cell viability, total protein production, alkaline phosphatase activity (ALP), mineral nodule formation, gene expression of collagen type I and ALP, and cell morphology were evaluated. RESULTS:
LLLT at 0.5 J/cm(2) increased cell viability of cultured osteoblasts. ALP activity and gene expression, in addition to mineral nodule formation and Col-I gene expression, were not increased by LLLT. LLLT applied to ZA-treated cells increased Col-I expression at 0.5, 1.5, and 3 J/cm(2) but did not improve any other cell activity assessed. CONCLUSION:
|
Authors | Fernanda Gonçalves Basso, Ana Paula Silveira Turrioni, Diana Gabiela Soares, Vanderlei Salvador Bagnato, Josimeri Hebling, Carlos Alberto de Souza Costa |
Journal | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
(Support Care Cancer)
Vol. 22
Issue 10
Pg. 2741-8
(Oct 2014)
ISSN: 1433-7339 [Electronic] Germany |
PMID | 24801347
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Bone Density Conservation Agents
- Diphosphonates
- Imidazoles
- Zoledronic Acid
|
Topics |
- Bisphosphonate-Associated Osteonecrosis of the Jaw
(therapy)
- Bone Density Conservation Agents
(pharmacology)
- Diphosphonates
(pharmacology)
- Humans
- Imidazoles
(pharmacology)
- Low-Level Light Therapy
(methods)
- Osteoblasts
(drug effects, physiology)
- Tumor Cells, Cultured
- Zoledronic Acid
|